Policy / Pricing RFK Jr. rewrites ACIP rules; Gilead, Roche dig into protein degraders BioPharma DiveThe newly published charter widens the required expertise to become an ACIP member and stresses vaccine safety.Policy / PricingRead full story pharminent April 10, 2026 (Last updated: April 10, 2026) BioPharma Dive The newly published charter widens the required expertise to become an ACIP member and stresses vaccine safety. Policy / PricingRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: With oral obesity race underway, all eyes are on Lilly’s Foundayo launchNext: Oricell closes a ‘pre-IPO’ megaround to aim CAR-T at solid tumors Related Stories Policy / Pricing US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028 pharminent July 22, 2026 Policy / Pricing UK commits to pharma IP protection in Swiss trade deal pharminent July 16, 2026 Policy / Pricing Germany approves healthcare costs overhaul despite significant pharma opposition pharminent July 13, 2026
